Mitra

Trajan Signs Agreement with GenTegra to Distribute RNA Stabilization Solution for Mitra-VAMS Microsampling

Retrieved on: 
Tuesday, November 28, 2023

PLEASANTON, Calif. and TORRANCE, Calif., Nov. 28, 2023 /PRNewswire-PRWeb/ -- Trajan Scientific and Medical (Trajan), a global developer and manufacturer of analytical and life sciences products, today announced they have signed an agreement with GenTegra, an innovator of biological sample protection solutions, to distribute the GenTegraRNA-NEO Active Chemical Protection™ technology. GenTegra's protection solution, designed exclusively for Trajan, can be applied to Trajan's Neoteryx Mitra® microsampling devices based on VAMS® technology for RNA-based studies. Once treated, the devices are intended to provide researchers with high-quality RNA recovery from remote blood microsamples that don't require cold-shipping or storage for up to 7 days before extraction. The GenTegraRNA-NEO technology protects against naturally occurring nucleases and environmental stresses that could degrade the RNA in blood samples.

Key Points: 
  • GenTegra's protection solution, designed exclusively for Trajan, can be applied to Trajan's Neoteryx Mitra® microsampling devices based on VAMS® technology for RNA-based studies.
  • "GenTegra is proud to collaborate with Trajan in introducing the GenTegraRNA-NEO Active Chemical Protection™ technology, exclusively tailored for Neoteryx Mitra® microsampling devices," said Robert (Bob) Barrett, President, GenTegra.
  • "GenTegra is proud to collaborate with Trajan in introducing the GenTegraRNA-NEO Active Chemical Protection™ technology, exclusively tailored for Neoteryx Mitra® microsampling devices," said Robert (Bob) Barrett, President, GenTegra.
  • "The overwhelmingly positive feedback from early users reinforces the impact of GenTegraRNA-NEO technology coupled with Mitra microsampling devices."

Metabolon Collaborates with Trajan on Microsampling Solutions for Metabolomics Research

Retrieved on: 
Monday, November 20, 2023

MORRISVILLE, N.C. and TORRANCE, Calif., Nov. 20, 2023 /PRNewswire/ -- Metabolon, Inc., the global leader in providing metabolomics solutions advancing a wide variety of life science research, and Trajan Scientific and Medical, creator of Neoteryx Mitra® biological sample collection devices based on VAMS® technology, announce a partnership to collaborate on microsampling solutions for metabolomics research.   

Key Points: 
  • MORRISVILLE, N.C. and TORRANCE, Calif., Nov. 20, 2023 /PRNewswire/ -- Metabolon, Inc., the global leader in providing metabolomics solutions advancing a wide variety of life science research, and Trajan Scientific and Medical, creator of Neoteryx Mitra® biological sample collection devices based on VAMS® technology, announce a partnership to collaborate on microsampling solutions for metabolomics research.
  • Life science research studies are frequently constrained by their inability to easily and efficiently secure adequate, stable biological samples.
  • Mitra devices offer precision via a volumetric absorptive microsampling method that is minimally invasive and user-friendly.
  • To learn more about metabolomics and how Metabolon is partnering with Trajan to take advantage of Neoteryx Mitra collection devices based on VAMS technology, please visit the Metabolon website or Neoteryx website .

Metabolon Collaborates with Trajan on Microsampling Solutions for Metabolomics Research

Retrieved on: 
Monday, November 20, 2023

MORRISVILLE, N.C. and TORRANCE, Calif., Nov. 20, 2023 /PRNewswire/ -- Metabolon, Inc., the global leader in providing metabolomics solutions advancing a wide variety of life science research, and Trajan Scientific and Medical, creator of Neoteryx Mitra® biological sample collection devices based on VAMS® technology, announce a partnership to collaborate on microsampling solutions for metabolomics research.

Key Points: 
  • MORRISVILLE, N.C. and TORRANCE, Calif., Nov. 20, 2023 /PRNewswire/ -- Metabolon, Inc., the global leader in providing metabolomics solutions advancing a wide variety of life science research, and Trajan Scientific and Medical, creator of Neoteryx Mitra® biological sample collection devices based on VAMS® technology, announce a partnership to collaborate on microsampling solutions for metabolomics research.
  • Life science research studies are frequently constrained by their inability to easily and efficiently secure adequate, stable biological samples.
  • Mitra devices offer precision via a volumetric absorptive microsampling method that is minimally invasive and user-friendly.
  • To learn more about metabolomics and how Metabolon is partnering with Trajan to take advantage of Neoteryx Mitra collection devices based on VAMS technology, please visit the Metabolon website or Neoteryx website .

Outreach Announces Abhijit Mitra as President of Product and Technology

Retrieved on: 
Thursday, October 26, 2023

SEATTLE, Oct. 26, 2023 /PRNewswire/ -- Outreach, the leading AI Sales Platform helping revenue organizations create better pipeline and close more deals, today announced engineering veteran Abhijit Mitra as its new President of Product and Technology. Mitra will lead the Product, Design, and Engineering (PDE) organization.

Key Points: 
  • Product and Engineering Veteran to Lead Sales Execution Platform Expansion Across New Verticals and Personas, Continue Enterprise Growth
    SEATTLE, Oct. 26, 2023 /PRNewswire/ -- Outreach , the leading AI Sales Platform helping revenue organizations create better pipeline and close more deals, today announced engineering veteran Abhijit Mitra as its new President of Product and Technology.
  • Mitra will lead the Product, Design, and Engineering (PDE) organization.
  • As a business and customer-oriented leader, Abhijit will work closely with David Ruggiero, Outreach President of GTM, to bring these new innovations to market.
  • "When searching for our Product and Technology President, we wanted someone with visionary excellence to lead Outreach in our platform journey," said Manny Medina, CEO and Co-founder of Outreach.

Trajan's Microsampling Devices Meet IVDR Compliance in Europe, UK

Retrieved on: 
Friday, June 2, 2023

MELBOURNE, Australia, June 2, 2023 /PRNewswire/ -- Trajan Scientific and Medical, a leading provider of analytical and life sciences products and solutions, today announced the regulatory approval of its Neoteryx remote blood microsampling devices, Mitra® and hemaPEN® for clinical use in Europe and the United Kingdom.

Key Points: 
  • Trajan has successfully fulfilled the required product safety and performance requirements under the In Vitro Diagnostic Medical Devices Regulation (IVDR) in Europe and the Medicines and Healthcare Products Regulatory Agency (MHRA) in the United Kingdom.
  • Having earned this CE Mark regulatory compliance, Trajan expands the capabilities of its Neoteryx® microsampling products to provide decentralised, person-centered, minimally invasive blood collection in both clinical and research settings.
  • Mitra® and hemaPEN® devices can be used remotely to collect blood samples through an easy, virtually painless process.
  • "The updated regulatory approval of Trajan's blood microsampling devices in the UK and European Union is another step forward towards our vision of personalized, preventative data-based healthcare," said Stephen Tomisich, CEO and founder of Trajan.

Trajan's Microsampling Devices Meet IVDR Compliance in Europe, UK

Retrieved on: 
Friday, June 2, 2023

MELBOURNE, Australia, June 2, 2023 /PRNewswire/ -- Trajan Scientific and Medical, a leading provider of analytical and life sciences products and solutions, today announced the regulatory approval of its Neoteryx remote blood microsampling devices, Mitra® and hemaPEN® for clinical use in Europe and the United Kingdom.

Key Points: 
  • Trajan has successfully fulfilled the required product safety and performance requirements under the In Vitro Diagnostic Medical Devices Regulation (IVDR) in Europe and the Medicines and Healthcare Products Regulatory Agency (MHRA) in the United Kingdom.
  • Having earned this CE Mark regulatory compliance, Trajan expands the capabilities of its Neoteryx® microsampling products to provide decentralised, person-centered, minimally invasive blood collection in both clinical and research settings.
  • Mitra® and hemaPEN® devices can be used remotely to collect blood samples through an easy, virtually painless process.
  • "The updated regulatory approval of Trajan's blood microsampling devices in the UK and European Union is another step forward towards our vision of personalized, preventative data-based healthcare," said Stephen Tomisich, CEO and founder of Trajan.

Boston University's Pregnancy Study Online (PRESTO) Expands with Remote Microsampling by Trajan

Retrieved on: 
Monday, March 6, 2023

BOSTON and LOS ANGELES, March 6, 2023 /PRNewswire-PRWeb/ -- The Pregnancy Study Online (PRESTO) at Boston University, which investigates environmental influences on fertility and miscarriage, expanded its protocol this year to offer at-home biospecimen collection to participants across 48 states. The PRESTO research team is conducting a sub-study called the Environmental Pregnancy Study Online (E-PRESTO), using biospecimen analysis to learn if certain chemicals in the environment are harmful to reproductive health. To encourage participation of couples across a wider geographical area, the researchers are offering a mail-based E-PRESTO option, shipping sampling kits to participants' homes. Trajan's Mitra® devices are included in the mailed kits for remote self-collection of blood samples using a quick finger-prick method. The kits also include collection cups to facilitate urine collection at home. All samples are mailed back to BU for storage and analysis at various external laboratories over the next 2 years. After analysis, participants receive a report of their exposure to chemicals and how to reduce exposure levels.

Key Points: 
  • The PRESTO research team is conducting a sub-study called the Environmental Pregnancy Study Online (E-PRESTO), using biospecimen analysis to learn if certain chemicals in the environment are harmful to reproductive health.
  • Trajan's Mitra® devices are included in the mailed kits for remote self-collection of blood samples using a quick finger-prick method.
  • The E-PRESTO researchers encourage study participants in the Boston or Detroit areas to participate in traditional venipuncture blood draws in their respective clinics.
  • To enroll in PRESTO & E-PRESTO, click on the study invitation link or contact the BU research team at: [email protected] or 617-358-3424.

Hound Labs Names Debkishore Mitra as Chief Technology Officer

Retrieved on: 
Wednesday, February 22, 2023

FREMONT, Calif., Feb. 22, 2023 (GLOBE NEWSWIRE) -- Hound Labs, Inc. , the leader in ultra-sensitive, automated, and analytical breath technologies and creator of the HOUND® CANNABIS BREATHALYZER,1 welcomes Debkishore (Deb) Mitra as its Chief Technology Officer (CTO).

Key Points: 
  • FREMONT, Calif., Feb. 22, 2023 (GLOBE NEWSWIRE) -- Hound Labs, Inc. , the leader in ultra-sensitive, automated, and analytical breath technologies and creator of the HOUND® CANNABIS BREATHALYZER,1 welcomes Debkishore (Deb) Mitra as its Chief Technology Officer (CTO).
  • In his role, Mitra will lead the company’s research and development department and oversee the architecture, design, scientific testing, commercialization, and expansion of Hound Labs’ product offerings.
  • Mitra will partner with the manufacturing team to ramp production of the HOUND® CANNABIS BREATHALYZER in spring 2023.
  • For more information about the HOUND® CANNABIS BREATHALYZER and to reserve a shipping window, contact the Hound Labs sales team .

Remote Work, Global Hiring Drive Explosive Growth in 'Employer of Record' Partnerships--Everest Group

Retrieved on: 
Tuesday, February 21, 2023

DALLAS, Feb. 21, 2023 /PRNewswire-PRWeb/ -- Everest Group research suggests that 71% of organizations want to improve their geographical footprint; however, global expansion can be a complex and lengthy process, with organizations needing to navigate new legal systems, regulations, taxes, cultures, languages and more. Enterprises are discovering that Employer of Record (EOR) arrangements can ease the burden of international expansion; accordingly, the EOR market swelled 170% in 2020 and 120% in 2022 and is expected to continue to grow at a compound annual growth rate of 40-50% through 2025 according to Everest Group.

Key Points: 
  • An Employer of Record is a third-party organization that becomes the full legal employer of a company's workforce and assumes all employee-related responsibilities in a particular country.
  • With an EOR, enterprises can onboard and manage talent without needing to establish a new legal entity in a particular region or risk violating local laws.
  • Adoption by industry: The services industry has the highest market share followed by the financial and healthcare industries.
  • Based on Everest Group's comprehensive evaluation framework, the PEAK Matrix® , 15 leading EOR providers evaluated are segmented into three categories:

Clearday’s Companion Robotics Robot Mitra Shows Tremendous Acceptance by TRECS Institute which Expanded their Grant Application Program Into 30 States for the 1st qtr. of 2023

Retrieved on: 
Wednesday, January 11, 2023

Clearday and TRECS are working together to introduce companion robots into leading skilled nursing homes to support cost savings, limit hospital readmissions and relieve caregiver burnout.

Key Points: 
  • Clearday and TRECS are working together to introduce companion robots into leading skilled nursing homes to support cost savings, limit hospital readmissions and relieve caregiver burnout.
  • These additional communities would provide a significant footprint in North Carolina and Florida to accelerate robotics in those states.
  • The number of facilities in North Carolina and Florida provide a large market for Clearday to offer the Mitra companion robot and services.
  • The opportunity to provide our robotics to over 15,000 patients and residents will be exceptionally rewarding both emotionally and financially to Clearday.”